 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              Ranbaxy Laboratories Ltd has notified the Bank of New York Mellon (hereinafter "The Bank") to terminate the Deposit Agreements dated July 7, 1994 (under which the Rule 144A Global Depositary Shares / Regulation S Global Depositary Shares have been issued) and underlying GDR programme. The Bank has on October 15, 2014 issued the notice of termination of GDR Programme to the GDR holders and accordingly the Bank will complete the process of termination of GDR programme as per the terms of such notice of termination.
Shares of RANBAXY LABORATORIES LTD. was last trading in BSE at Rs.589.85 as compared to the previous close of Rs. 598.05. The total number of shares traded during the day was 96754 in over 3648 trades.
The stock hit an intraday high of Rs. 605.8 and intraday low of 586.6. The net turnover during the day was Rs. 57855935.